03 Nov 2026, 08:41 IST
Dr. Reddy's Laboratories Limited
India IPO
The report states the US FDA approved Dr. Reddy's India-made generic lenacapavir, a twice-yearly HIV prevention injection.
From k869b72oa5, written by India IPO and hosted by IndiaIPO. Orivam summarised it; the view is India IPO's, not Orivam's.
Open the original PDF on IndiaIPO →Research PDFs are often removed by the firms that publish them. The summary above is kept so this page still means something if that happens.